<DOC>
	<DOCNO>NCT01984580</DOCNO>
	<brief_summary>Using orally administer zinc patient already diagnose pre-cancerous condition , Barrett 's Esophagus , study ask two question : 1. zinc administration cause molecular-level change Barrett 's tissue ? 2. change measure indicative chemopreventive action zinc regard cancer progression ?</brief_summary>
	<brief_title>Effect Zinc Barrett 's Metaplasia</brief_title>
	<detailed_description>14 day prior already-scheduled upper endoscopy ( EGD ) procedures routine surveillance Barrett 's tissue , patient give write , informed consent randomize ( seal envelope method ) place oral dose zinc gluconate ( 26.6 mg zinc BID ) placebo ( molar equivalent sodium gluconate BID ) 14 day . At time endoscopy , 4 biopsy take ( pool ) Barrett 's tissue 4 proximal normal esophageal tissue . Biopsies flash frozen later analyse atomic absorption spectroscopy , PAGE Western immunoblot RNA microarray .</detailed_description>
	<mesh_term>Metaplasia</mesh_term>
	<mesh_term>Barrett Esophagus</mesh_term>
	<mesh_term>Zinc</mesh_term>
	<criteria>age 1880 ; prior diagnosis Barrett 's esophagus unable provide write , informed consent ; prior history Barrett 's dysplasia esophageal adenocarcinoma ; drug exclusion : hormone replacement therapy , cholestyramine , amiloride diuretic , oral quinolone antibiotic , glucocorticoid , corticosteroid , anticoagulant ( aspirin )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Barrett 's esophagus</keyword>
	<keyword>Esophagus</keyword>
	<keyword>Adenocarcinoma</keyword>
</DOC>